Overview

A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications

Status:
Terminated
Trial end date:
2020-08-24
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the clinical and virologic benefit of pimodivir in combination with Standard-of-Care (SOC) treatment compared to placebo in combination with SOC treatment.
Phase:
Phase 3
Details
Lead Sponsor:
Janssen Research & Development, LLC